11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Matrix metalloproteinase 10 contributes to hepatocarcinogenesis in a novel crosstalk with the stromal derived factor 1/C-X-C chemokine receptor 4 axis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Matrix metalloproteinases (MMPs) participate in tissue repair after acute injury, but also participate in cancer by promoting a protumorigenic microenvironment. Previously, we reported on a key role for MMP10 in mouse liver regeneration. Herein, we investigated MMP10 expression and function in human hepatocellular carcinoma (HCC) and diethylnitrosamine (DEN)-induced mouse hepatocarcinogenesis. MMP10 was induced in human and murine HCC tissues and cells. MMP10-deficient mice showed less HCC incidence, smaller histological lesions, reduced tumor vascularization, and less lung metastases. Importantly, expression of the protumorigenic, C-X-C chemokine receptor-4 (CXCR4), was reduced in DEN-induced MMP10-deficient mice livers. Human HCC cells stably expressing MMP10 had increased CXCR4 expression and migratory capacity. Pharmacological inhibition of CXCR4 significantly reduced MMP10-stimulated HCC cell migration. Furthermore, MMP10 expression in HCC cells was induced by hypoxia and the CXCR4 ligand, stromal-derived factor-1 (SDF1), through the extracellular signal-regulated kinase 1/2 pathway, involving an activator protein 1 site in MMP10 gene promoter.

          Related collections

          Author and article information

          Journal
          Hepatology
          Hepatology (Baltimore, Md.)
          1527-3350
          0270-9139
          Jul 2015
          : 62
          : 1
          Affiliations
          [1 ] Division of Hepatology, CIMA, University of Navarra, Pamplona, Spain.
          [2 ] Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
          [3 ] Microscopic and Ultrastructural Anatomy, Center for Integrated Biomedical Research- CIR, University Campus Bio-Medico of Rome, Rome, Italy.
          [4 ] CIBEREHD, University Clinic Navarra, Instituto de Salud Carlos III, Pamplona, Spain.
          [5 ] Hepatology Unit, University Campus Bio-Medico of Rome, Rome, Italy.
          [6 ] Department of Digestive Diseases, Hospital Clinico San Carlos, Madrid, Spain.
          [7 ] Division of Cardiovascular Sciences, CIMA, University of Navarra, Pamplona, Spain.
          Article
          10.1002/hep.27798
          25808184
          6318ebcf-1259-4101-a201-b8f3023bf5cb
          © 2015 by the American Association for the Study of Liver Diseases.
          History

          Comments

          Comment on this article